Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adaptive Biotechnologies Corp (NQ: ADPT )

4.420 -0.340 (-7.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,094,568
Open 4.740
Bid (Size) 4.200 (1)
Ask (Size) 4.620 (3)
Prev. Close 4.760
Today's Range 4.395 - 4.785
52wk Range 2.605 - 10.79
Shares Outstanding 144,311,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
From Adaptive Biotechnologies
Via GlobeNewswire
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. 
Via Benzinga

Performance

YTD
-43.33%
-43.33%
1 Month
-7.92%
-7.92%
3 Month
-33.43%
-33.43%
6 Month
-42.60%
-42.60%
1 Year
-46.42%
-46.42%

More News

Read More
Recap: Adaptive Biotechnologies Q3 Earnings
Via Benzinga
Adaptive Biotechnologies's Earnings Outlook
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
From Adaptive Biotechnologies
Via GlobeNewswire
Expert Ratings for Adaptive Biotechnologies
Via Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
What's Going On With Adaptive Biotechnologies (ADPT) Stock?
Via Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Adaptive Announces Launch of Epic Integration for clonoSEQ®
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
Via InvestorPlace
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
Via Benzinga
Topics Earnings
Exposures Financial
Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead
Via Benzinga
Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples
Via Benzinga
Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company
Via Benzinga
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.